Neurosterix
Justine Paradis is a Senior Scientist and Project Lead at Neurosterix, a biopharmaceutical company specializing in allosteric modulators for neurological disorders, since April 2024. Prior to this role, Justine served as a Senior Scientist and Project Lead at Addex Therapeutics from May 2021 to April 2024, focusing on drug discovery and preclinical development of GPCR modulators, while managing project coordination and budgets. Justine has a strong academic background, including a PhD in Molecular Biology from Université de Montréal and postdoctoral research in cancer biology at the University of California, San Diego. Additional experience includes research roles at Servier, Universidad Autónoma de Madrid, and BiodOxis, complemented by a Micro-MBA from the Rady School of Management.
This person is not in any teams
Neurosterix
Neurosterix is a biopharmaceutical company focused on developing allosteric modulators for the treatment of neurological disorders. Our drug discovery and development platform identifies and develops allosteric modulators — molecules that increase or decrease the activity of target receptors by binding outside of the “active site” where endogenous ligands and traditional drugs operate. Through this platform, Neurosterix’s novel drug candidates have the potential to provide medicines with improved efficacy, safety and tolerability for patient communities suffering from underserved neurological disorders.